drugset / Trial / NCT00964366

Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications

NCT00964366

Phase 4 Completed 53 enrolled Stiefel, a GSK Company GlaxoSmithKline · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a randomized, half-face study. On 1 side of the face, the subject will apply 1 of the 2 test products, clindamycin and benzoyl peroxide or dapsone gel and the contra lateral side of the face will remain non-treated to serve as a control.

Timeline

Start
2009-07
Primary completion
2009-08
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Benzoyl Peroxide Other / unclassified Topical
Subject Clindamycin Unknown Topical
Comparator Dapsone Small molecule 5 % Topical

Indications